Wordt geladen...

The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studies

The treatment of breast cancer that is driven by amplification and overexpression of human epidermal growth factor receptor 2 (HER2) has been drastically improved by the development of HER2-targeted therapies including trastuzumab and lapatinib. While outcomes for patients diagnosed with HER2-positi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Hurvitz, Sara A., Kakkar, Reva
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2012
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3424498/
https://ncbi.nlm.nih.gov/pubmed/22942906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012451205
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!